DAVID CESSAR: Open Payments
NPI 1851912810 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 12 payments from 8 companies in 2025. Trend: 2023 $25 · 2024 $280 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $60 |
| Alexion Pharmaceuticals, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $13 |
Products named: General - DBS, ULTOMIRIS, KISUNLA, JOURNAVX, HORIZANT, ETERNA, ZAVZPRET, Cervical-Stim.
Industry payments across PA — which companies pay providers there.
